Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial. uri icon

authors

  • Allen, Jeffrey A
  • Hussain, Yessar M
  • Kuwabara, Satoshi
  • Le Masson, Gwendal
  • Leypoldt, Frank
  • Chang, Ting
  • Lipowska, Marta
  • Lowe, Murray
  • Lauria, Giuseppe
  • Querol, Luis
  • Simu, Mihaela-Adriana
  • Lin, Jie
  • Suresh, Niraja
  • Tse, Anissa
  • Ulrichts, Peter
  • Van Hoorick, Benjamin
  • Yamasaki, Ryo
  • Lewis, Richard A
  • van Doorn, Pieter A
  • Basta, Ivana
  • Dysgaard, Tina
  • Eggers, Christian
  • Guptill, Jeffrey T
  • Gwathmey, Kelly G
  • Hewamadduma, Channa
  • Hofman, Erik

publication date

  • October 2024